Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Fu-zhi Ji"'
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-7 (2021)
Abstract Background This retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and cisplatin in patients with locally advanced esophageal squamous cell carcinoma (ESCC). M
Externí odkaz:
https://doaj.org/article/28b23b409ff74b529fdb92d9be59816a
Autor:
Ying-Ying Xu, Xi-Lei Zhou, Chang-Hua Yu, Wan-Wei Wang, Fu-Zhi Ji, Dong-Cheng He, Wei-Guo Zhu, Yu-Suo Tong
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundSarcopenia has been associated with treatment-related toxicities and poor survival in cancer patients. Our aim was to investigate the prevalence of sarcopenia in postoperative recurrent esophageal squamous cell carcinoma (ESCC) patients rec
Externí odkaz:
https://doaj.org/article/5085539d27a74f59a57bc8e2fbf47539
Autor:
Tong Yusuo, Chang-Hua Yu, Wanwei Wang, Weiguo Zhu, Dong-Cheng He, Lili Yang, Xi-Lei Zhou, Yaozu Xiong, Fu-zhi Ji, Xiufeng Cao
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 1-13 (2020)
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 1-13 (2020)
Cancer-associated fibroblasts (CAFs), an activated subpopulation of fibroblasts, occupy a central position in the tumor microenvironment and have been shown to promote chemoresistance in multiple cancer types by secreting inflammatory cytokines. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148ed1833f9cf8b8ecfb7fada35a3461
https://doi.org/10.1016/j.omto.2020.05.014
https://doi.org/10.1016/j.omto.2020.05.014
Autor:
Yingying Xu, Dong-Cheng He, Tong Yusuo, Wanwei Wang, Weiguo Zhu, Chang-Hua Yu, Fu-zhi Ji, Xi-Lei Zhou
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2022)
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2022)
Frontiers in Oncology, Vol 11 (2021)
BackgroundSarcopenia has been associated with treatment-related toxicities and poor survival in cancer patients. Our aim was to investigate the prevalence of sarcopenia in postoperative recurrent esophageal squamous cell carcinoma (ESCC) patients rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46af47ecbd088085e65e36a5134e074d
http://europepmc.org/articles/PMC8766294
http://europepmc.org/articles/PMC8766294
Autor:
Tong Yusuo, Weiguo Zhu, Wei‐Jing Tao, Xi-Lei Zhou, Zhi‐Jian Zhu, Xue Deng, Fu-zhi Ji, Wanwei Wang
Publikováno v:
The Oncologist
Management of esophageal squamous cell carcinoma remains challenging, because detection often occurs at advanced stages and because of the high incidence of lymph node metastasis. This article focuses on whether lymphopenia is associated with respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105fc483a13b3a6d51296b282302d24b
https://doi.org/10.1634/theoncologist.2018-0723
https://doi.org/10.1634/theoncologist.2018-0723
Autor:
Xi-Lei Zhou, Yu, Chang-Hua, Wan-Wei Wang, Fu-Zhi Ji, Xiong, Yao-Zu, Zhu, Wei-Guo, Yu-Suo Tong
Additional file 1: Table S1. Treatment-related toxicities in patients > 60 years.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccd75e3d17d417e9099801debdbc496c
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-7 (2021)
Radiation Oncology, Vol 16, Iss 1, Pp 1-7 (2021)
BackgroundThis retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and cisplatin in patients with locally advanced esophageal squamous cell carcinoma (ESCC).MethodsPatie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c29f483c100d501390e95e625438c1
https://pubmed.ncbi.nlm.nih.gov/34039375
https://pubmed.ncbi.nlm.nih.gov/34039375
Publikováno v:
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 16(9)
To compare the efficacy and toxicity of intensity- modulated radiation therapy plus chemotherapy (IMRT-TP) with simple intensity-modulated radiation therapy (IMRT) in the treatment of locally advanced esophageal carcinoma.A total of 170 eligible pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1959eb828c09bb5ef053deb4178951dd
https://pubmed.ncbi.nlm.nih.gov/24061990
https://pubmed.ncbi.nlm.nih.gov/24061990
Autor:
Xi-long Su, Guang-zhou Tao, Ji-hua Han, Fu-zhi Ji, Xiao-fei Chen, Cheng-shi Wang, Jian Ji, Yangsong Zuo, Xi-Lei Zhou, Jiang-guo Yi, Weiguo Zhu, Wenyi Shen, Yan-mei Xu, Cheng-dong Zong, Juan Pu
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 110(1)
Objective The efficacy of postoperative concurrent radiochemotherapy (POCRT) on IIIA-pN2 non-small cell lung cancer (NSCLC) is still unclear. The aim of this randomized controlled trial was to compare POCRT with postoperative chemotherapy (POCT) alon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64f0c3748d1eb25c68e073b6a1b80c8
https://pubmed.ncbi.nlm.nih.gov/25037929
https://pubmed.ncbi.nlm.nih.gov/25037929
Autor:
Peng Pan, Yan Zhang, Chang-Hua Yu, Ji-Hua Han, Xi-Lei Zhou, Tao Li, Jin-xia Ding, Wei-guo Zhu, J. Ji, Fu-zhi Ji, Guang-zhou Tao, K. Zhou
Publikováno v:
Diseases of the Esophagus.
Primary, small-cell esophageal carcinoma (SCEC) is a rare but highly malignant tumor. Due to lack of randomized, controlled, prospective studies, there are currently no unified treatment modalities for SCEC. This study retrospectively analyzed the ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4aaa70f50c7eaf7fc3a8664d49efeec4
https://doi.org/10.1111/dote.12017
https://doi.org/10.1111/dote.12017